EP2269622
CpG ólígónúkleótíð notað til að auka virkni stera hjá sjúklingi sem er háður sterum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.6.2006EP published:
25.12.2013EP application number:
10162989.7
EP translation filed:
25.2.2014Grant published:
15.3.2014EPO information:
European Patent Register
Max expiry date:
28.6.2026Expiry date:
28.6.2022
Title:
CpG oligonucleotides used for enhancing steroid activity in a steroid dependent patient
Timeline
Today
29.6.2006EP application
25.12.2013EP Publication
25.2.2014Translation submitted
15.3.2014Registration published
28.6.2022Expires
Owner
Name:
Index Pharmaceuticals ABAddress:
Scheeles väg 2, 171 77 Stockholm, SE
Inventor
Name:
Löfberg, RobertAddress:
113 40 Stockholm, SE
Name:
von Stein, OliverAddress:
194 34 Upplands Väsby, SE
Name:
Zargari, ArezouAddress:
170 74 Solna, SE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
696173 PDate:
1.7.2005Country:
US
Classification
Categories:
A61K 38/00, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 24.6.2014
Expires: 28.6.2015
Payer: Árnason Faktor
Number: 10
Paid: 26.6.2015
Expires: 28.6.2016
Payer: Árnason Faktor
Number: 11
Paid: 21.6.2016
Expires: 28.6.2017
Payer: Árnason Faktor
Number: 12
Paid: 12.6.2017
Expires: 28.6.2018
Payer: Árnason Faktor
Number: 13
Paid: 25.6.2018
Expires: 28.6.2019
Payer: Tego ehf.
Number: 14
Paid: 24.6.2019
Expires: 28.6.2020
Payer: Tego ehf.
Number: 15
Paid: 23.6.2020
Expires: 28.6.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 24.6.2021
Expires: 28.6.2022
Payer: Árnason Faktor ehf.